2024
DOI: 10.1021/acsptsci.4c00085
|View full text |Cite
|
Sign up to set email alerts
|

Energy Blocker Lonidamine Reverses Nimustine Resistance in Human Glioblastoma Cells through Energy Blockade, Redox Homeostasis Disruption, and O6-Methylguanine-DNA Methyltransferase Downregulation: In Vitro and In Vivo Validation

Yaxing Huang,
Peng Wang,
Tengjiao Fan
et al.

Abstract: Tumor resistance seriously hinders the clinical application of chloroethylnitrosoureas (CENUs), such as O 6methylguanine-DNA methylguanine (MGMT), which can repair O 6 -alkyl lesions, thereby inhibiting the formation of cytotoxic DNA interstrand cross-links (ICLs). Metabolic differences between tumor and normal cells provide a biochemical basis for novel therapeutic strategies aimed at selectively inhibiting tumor energy metabolism. In this study, the energy blocker lonidamine (LND) was selected as a chemo-sen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 45 publications
(132 reference statements)
0
0
0
Order By: Relevance